Is there a clinical role for frozen section analysis during partial nephrectomy? A multicenter experience over 10 years

Minerva Urol Nefrol. 2020 Jun;72(3):332-338. doi: 10.23736/S0393-2249.19.03110-2. Epub 2019 Dec 11.

Abstract

Background: Frozen section analysis (FSA) is frequently performed during partial nephrectomy (PN). We investigate the utility of intraoperative FSA by evaluating its impact on final surgical margin (SM) status.

Methods: Between January 1995 and December 2005, a series of patients who were treated with open PN for renal cell carcinoma was prospectively analyzed. During PN, each patient underwent a FSA on renal parenchyma distal margin. If FSA was positive for infiltration a deeper excision was performed till obtaining a negative FSA. SM outcome of the FSA was compared with the final pathology report. Recurrence-free survival (RFS) and cost analysis on the FSA performed were analyzed.

Results: A total number of 373 patients were enrolled. FSA was performed in all the patients considered for PN. Fifteen patients had a conversion to radical nephrectomy. Positive SMs at the definitive pathological outcome were found in 36 patients (9.6%). FSA was positive in eight patients (2.1%). In that eight cases after a deeper excision the definitive pathological outcome on SM was still positive in two cases. FSA revealed just 14.3% of the positive SM. Patients with positive SM had a worse follow up considering RFS (P<0.05). Kaplan-Meier analysis revealed that FSA did not considerably contribute to prevent recurrence (P=0.35). 1438 euros was the mean cost of performing a FSA during PN.

Conclusions: FSA during PN does not reduce the risk of positive SMs. The use of FSA has also a higher cost related to the procedure.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Carcinoma, Renal Cell / economics
  • Carcinoma, Renal Cell / surgery
  • Female
  • Frozen Sections* / economics
  • Humans
  • Kaplan-Meier Estimate
  • Kidney Neoplasms / economics
  • Kidney Neoplasms / surgery
  • Male
  • Margins of Excision
  • Middle Aged
  • Neoplasm Recurrence, Local / economics
  • Neoplasm Recurrence, Local / prevention & control
  • Nephrectomy / economics
  • Nephrectomy / methods*
  • Prospective Studies
  • Treatment Outcome